EJNMMI Research

Table 1 Clinical characteristics of 210 subjects

From: [^99mTc]Tc-Galacto-RGD₂ integrin α_vβ₃-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data

Variants	Lung cancer	Benign disease	p
General
Age (years)	64.17 ± 10.15	61.04 ± 12.77	0.25
Sex
Male	133 (56.00%)	14 (71.89%)
Female	52 (44.00%)	11 (28.11%)	0.16
Cancer type
LAC	97 (52.43%)
LSC	48 (25.95%)
SCLC	22 (11.89%)
Other	18 (9.73%)
Stage
I	37 (20.00%)
II	13 (7.03%)
III	40 (21.62%)
IV	95 (51.35%)

LAC adenocarcinoma, LSC squamous cell carcinoma, SCLC small cell lung cancer

Back to article page